Reduce Risk, Cost and Time in the New Era of Small Molecule Drug Discovery Webinar
The webinar on August 18 at 4pm BST/11am EDT will address the challenges in small molecule drug discovery by presenting strategies to reduce risk, cost, and time, featuring expert Haydn Boehm who brings 20 years of life science industry experience and a PhD in Organic Chemistry.
Online
Webinar: Reduce Risk, Cost and Time in the New Era of Small Molecule Drug Discovery
August 18
4pm BST / 11am EDT
With the renaissance of Small Molecule Drug Discovery, the race to explore uncharted biologically active chemical space is on. However, the process of discovery has multiple challenges that have an impact on time, cost and risk to any Biotech working towards a therapeutic breakthrough.
Join us for our webinar on 18 August at 4pm BST/11am EDT, where we will highlight the challenges and show how to remove these avoidable risks, costs and time to accelerate your path to discovery.
Featured Speakers
Haydn Boehm
Haydn is focused on helping the life science and drug discovery industries learn how to harmonize their science and data, and accelerate innovation to make the world a healthier, cleaner, better place to live. Haydn has 20 years sales and marketing leadership experience in the life science industry working with companies such as ThermoFisher Scientific, Johnson Matthey and more recently with Merck KGaA’s Connected Lab Program. Haydn has a PhD in Organic Chemistry from the University of Nottingham, UK., and lives on the Jurassic Coast in Devon, UK with his family.